Do not use insulin aspart in fixed combination with insulin aspart protamine in infusion pumps.Rotate infusion sites within the same region.Recommended for use in certain external infusion pumps (i.e., Minimed model 500 series, Disetronic H-TRON series or other equivalent pump).IV...
Insulin degludec 100- and 200-units/mL formulations are pharmacodynamically and pharmacokinetically bioequivalent; do not perform dose conversions between the 100- and 200-units/mL FlexTouch injection pens based on differences in insulin concentration. The dose window on these injection pens displays ...
Switching between these insulins involves a one-to-one conversion; for example, 10 units of insulin glulisine is equivalent to 10 units of insulin aspart. Ultra-Rapid-Acting Insulins The newest type of insulin is insulin aspart (Fiasp), which is classified as an ultra-rapid-acting insulin. ...
product Lantus®*. The two studies were 26 weeks in duration and enrolled subjects with type 1 (n=576) and type 2 diabetes mellitus (n=567), respectively. In the studies, Gan & Lee Insulin Glargine Injection demonstrated equivalent/comparable immunogenicity, efficacy, and safety to Lantus®...
One part diluent will yield a concentration one-half that of NOVOLOG (equivalent to U-50). Continuous Subcutaneous Infusion (Insulin Pump) Can use this NOVOLOG product with the continuous subcutaneous insulin infusion pumps labeled for use with NOVOLOG (insulin aspart). Refer to the insulin pu...
Global spending on diabetes care was reported to be at least $760 billion in 201910. Since type 1 and chronic type 2 diabetes requires almost lifelong insulin use, this cost present a serious financial burden on diabetes patients and their families. High-quality bioequivalent formulations, approve...
(human insulin desB30 back-bone) with an identical fatty acid side chain to OI338 and OI320 has much lower bioavailability, emphasising the importance of stabilisation of the insulin backbone (Fig.3c). Furthermore, the oral bioavailability of insulin aspart, a marketed rapid-acting insulin ...
patients should be instructed to administer a once daily dose of glargine equivalent to the total 24-hour basal dose. If the patient has ultralente, the total dose (which is again equivalent to the total basal rate) should be split between the morning and evening. All doses of short- or...
(difference −0.53%, 95% CI −0.66, −0.40, p-value <0.001), with equivalent hypoglycemia risk and less weight gain [15]. Thus, fixed-dose GLP-1 RA/basal insulin formulations can be considered as first injectable therapy in select patients with uncontrolled diabetes, however it is ...
The amount of dapagliflozin is theoretically equivalent to 81.29% of dapagliflozin propylene glycol hydrate, either of which can be used. The actual amount of dapagliflozin propylene glycol hydrate will depend on the purity. The microcrystalline cellulose is the compensating excipient whose amount can va...